menu
    • menu

    Company profile for Eusa Pharma

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in March 2015, EUSA Pharma is a world-class biopharmaceutical company focused on oncology and rare disease. The company has extensive commercial operations in the United States and Europe, alongside a direct presence in select other markets across the globe. EUSA Pharma is led by an experienced management team with a strong record of building successful pharmaceutical companies, and is supported by significant funding ...
    Founded in March 2015, EUSA Pharma is a world-class biopharmaceutical company focused on oncology and rare disease. The company has extensive commercial operations in the United States and Europe, alongside a direct presence in select other markets across the globe. EUSA Pharma is led by an experienced management team with a strong record of building successful pharmaceutical companies, and is supported by significant funding raised from leading life science investor EW Healthcare Partners.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eusa PharmaFrance Flag
    Country
    Country
    France
    Address
    Address
    LES JARDINS D'ECOLE, 3 ALL╔E DES S╔QUOIAS
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://eusapharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Recordati acquires EUSA Pharma & its 4 rare disease drugs, but analysts question
    Recordati acquires EUSA Pharma & its 4 rare disease drugs, but analysts question

    06 Dec 2021

    // ENDPTS

    https://endpts.com/recordati-acquires-eusa-pharma-and-its-4-rare-disease-drugs-but-analysts-question-strategy-behind-the-deal/

    ENDPTS
    06 Dec 2021
    Share Share
    CVC-controlled Recordati buys UK start-up to expand rare cancers portfolio
    CVC-controlled Recordati buys UK start-up to expand rare cancers portfolio

    04 Dec 2021

    // FT

    https://www.ft.com/content/08909894-6a84-40ad-8d87-6a9781d7011f

    FT
    04 Dec 2021
    Share Share
    BeiGene, EUSA Announce NMPA Approval of SYLVANT for iMCD
    BeiGene, EUSA Announce NMPA Approval of SYLVANT for iMCD

    02 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211202006046/en

    BUSINESSWIRE
    02 Dec 2021
    Share Share
    BeiGene and EUSA Pharma Announce NMPA Approval of SYLVANT®
    BeiGene and EUSA Pharma Announce NMPA Approval of SYLVANT®

    02 Dec 2021

    // PRESS RELEASE

    https://ir.beigene.com/news-details/?id=f0f5a767-78bb-4998-9593-5f9ea685026e

    PRESS RELEASE
    02 Dec 2021
    Share Share
    BeiGene and EUSA Pharma announce China NMPA approval of QARZIBA.
    BeiGene and EUSA Pharma announce China NMPA approval of QARZIBA.

    17 Aug 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210817005630/en

    BUSINESSWIRE
    17 Aug 2021
    Share Share
    EUSA Pharma & BeiGene Announce Acceptance of a BLA for SYLVANT®
    EUSA Pharma & BeiGene Announce Acceptance of a BLA for SYLVANT®

    25 Jan 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210125005360/en/EUSA-Pharma-and-BeiGene-Announce-Acceptance-of-a-Biologics-License-Application-for-SYLVANT%C2%AE-Siltuximab-for-Injection-in-China

    BUSINESSWIRE
    25 Jan 2021
    Share Share

    ABOUT THIS PAGE

    Contact Eusa Pharma and get a quotation

    Eusa Pharma is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Dinutuximab bulk with DMF offered by Eusa Pharma

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search